Research at Radial

Backed by research.
Driven by care.

Radial clinicians don't just follow the research, they conduct it. From neuromodulation to digital psychiatry, our team actively publishes and participates in clinical trials, ensuring every patient receives care that is grounded in the best available evidence.

Publications

April 2026
Psychedelic Therapy
Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview
Burton J Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
Psychedelic therapy didn't begin in research labs — it has a long, complex history worth understanding. This primer traces the historical foundations of psychedelic medicine, providing primary care clinicians with context for the current therapeutic renaissance.
No items found.
Psychedelic Therapy
April 2026
Psychedelic Therapy
Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin
Burton J Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D Beutler, Kirsten Cherian, Viviana D Evans, Chelsey Fasano, Owen S Muir
Psilocybin is arriving in clinical conversations faster than most primary care clinicians feel prepared for. This primer equips frontline providers with the evidence base, clinical context, and safety considerations needed to counsel patients meaningfully.
No items found.
Psychedelic Therapy
April 2026
Accelerated TMS
Real-world outcomes and predictors of accelerated rTMS treatment response for treatment-resistant depression
Danielle D DeSouza, Erica Nakano, Vivian Hoang, Kim Hoang, David Ling, Owen Muir, Nathan Meng, Noah DeGaetano, Shan H Siddiqi, David Carreon
Who responds to accelerated TMS in the real world — and what predicts success? This analysis of real-world treatment data identifies clinical and demographic factors associated with response, helping clinicians better match patients to this intensive protocol.
No items found.
Accelerated TMS
April 2026
Deep TMS
Accelerated Dtms Utilization Of H7 Coil For Comorbid Trd: A Case Series
Aslam MacMillan, Carlene MacMillan, Owen Muir
Treatment-resistant depression with comorbidities demands more than standard protocols. This case series examines the use of accelerated dTMS with the H7 coil in complex patients, documenting outcomes that support its use in harder-to-treat presentations.
No items found.
Deep TMS
April 2026
Mentalizing-Based Therapy
Basic Concepts in Mentalizing-Based Therapy for Emerging Personality Disorders
Laurel L Williams, Carl Fleisher, Owen S Muir, Chris Grimes, Carlene M MacMillan, Robert A Dugger
Personality difficulties in adolescence are often dismissed as a phase — but early intervention matters. This paper introduces core concepts of Mentalizing-Based Therapy for emerging personality disorders, equipping clinicians with a structured approach for younger patients.
No items found.
Mentalizing-Based Therapy
April 2026
Mentalizing-Based Therapy
Mentalizing-Based Therapy for Borderline Personality Disorder and Other “Difficult” Patients"
Laurel L Williams, Carl Fleisher, Efrain Bleiberg, Owen S Muir, Chris Grimes, Robert A Dugger
Borderline personality disorder in adolescents is frequently misunderstood and undertreated. This paper applies Mentalizing-Based Therapy to emerging personality disorders in teens, offering a developmentally grounded framework for clinicians working with this population.
No items found.
Mentalizing-Based Therapy
April 2026
Accelerated TMS
Cognitive changes and predictors of treatment outcome following accelerated rTMS treatment for depression
Kim Hoang, Laura Schulze, Erica Nakano, Vivian Hoang, David Ling, Shan Siddiqi, Owen Muir, Nate Meng, Noah DeGaetano, Danielle DeSouza, David Carreon
Can cognitive function predict who responds best to accelerated TMS? This study tracked cognitive changes before and after treatment, identifying baseline and post-treatment patterns that may help clinicians anticipate outcomes.
No items found.
Accelerated TMS
April 2026
Accelerated TMS
Impact of accelerated intermittent theta-burst stimulation on anxiety symptoms in major depressive disorder
Erica Nakano, Vivian Hoang, Kim Hoang, Laura Schulze, David Ling, Shan Siddiqi, Owen Muir, Nathan Meng, Noah DeGaetano, Danielle DeSouza, David Carreon
Depression and anxiety often travel together — so how well does accelerated TMS address both? This trial found that accelerated theta-burst stimulation produced meaningful reductions in anxiety symptoms alongside its established antidepressant effects.
No items found.
Accelerated TMS
April 2026
Accelerated TMS
Hourly mood assessments during accelerated rTMS for major depression: Trajectories of treatment response
Laura Schulze, Erica Nakano, Vivian Hoang, Kim Hoang, David Ling, Shan Siddiqi, Owen Muir, Nate Meng, Noah DeGaetano, Danielle DeSouza, David Carreon
When does relief actually begin during accelerated TMS — and can we track it hour by hour? This study used daily mood assessments to chart depression trajectories during treatment, revealing when and how quickly patients begin to respond.
No items found.
Accelerated TMS
April 2026
Psychedelic Therapy
Scaling Psychedelic Therapies in the Health System
B Traux, E Marseille, Owen Muir, J Glastra
Psychedelic therapies are moving from clinical trials into health systems — but the infrastructure isn't ready. This report outlines the policy, training, and operational frameworks needed to integrate psychedelic-assisted treatment at scale.
No items found.
Psychedelic Therapy
No items found.
No items found.
Personality Disorders
Narcissism
No items found.
No items found.
Mentalizing-Based Therapy
No items found.
Deep TMS
No items found.
Deep TMS
No items found.
Mentalizing-Based Therapy
No items found.
Mentalizing-Based Therapy
No items found.
Deep TMS
No items found.
AI / Digital Psychiatry
No items found.
No items found.
No items found.
Deep TMS
No items found.
Deep TMS
No items found.
Deep TMS
No items found.
Ketamine Monitoring
PTSD
Bipolar
TMS
Movement Disorders
AI / Digital Psychiatry
No items found.
Accelerated TMS
No items found.
AI / Digital Psychiatry
No items found.
Accelerated TMS
No items found.
No items found.
No items found.
Accelerated TMS
No items found.
TMS
No items found.
Psychedelic Therapy
No items found.
Psychedelic Therapy
No items found.
Psychedelic Therapy
No items found.
Psychedelic Therapy
No items found.
Psychedelic Therapy
No items found.
Psychedelic Therapy
No items found.
Psychedelic Therapy
No items found.
Psychedelic Therapy
No items found.
Deep TMS
No items found.
Mentalizing-Based Therapy
No items found.
Accelerated TMS
No items found.
Accelerated TMS
No items found.
Accelerated TMS
No items found.
No items found.
No items found.
Deep TMS
No items found.
Deep TMS
No items found.
No items found.
No items found.
Deep TMS
No items found.
Accelerated TMS
No items found.
Ketamine Therapy
Filter Publications
Conditions
Treatments
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Active Clinical Trials

AI / Digital Psychiatry

Cross-Dataset Evaluation of an Automated Video-Based Model for Detecting Tardive Dyskinesia Using the Clinician's Tardive Inventory: Validation Study

Can AI reliably spot a movement disorder that clinicians routinely miss? This validation study found that an AI-powered video analysis model accurately detected tardive dyskinesia — a common side effect of long-term antipsychotic use — even when video recordings weren't collected under standardized conditions. The model showed strong agreement with expert clinician ratings and high diagnostic accuracy, suggesting it could support earlier, more consistent screening in real-world clinical settings.
View
Trosch R, Sterns A, Grimm B, Larsen L, Talbot B, Ma F, Ranjan R, MacMillan C, Hughes J, Friedman J, Muir O
Can AI reliably spot a movement disorder that clinicians routinely miss? This validation study found that an AI-powered video analysis model accurately detected tardive dyskinesia — a common side effect of long-term antipsychotic use — even when video recordings weren't collected under standardized conditions. The model showed strong agreement with expert clinician ratings and high diagnostic accuracy, suggesting it could support earlier, more consistent screening in real-world clinical settings.

Leadership

Dr. Owen Scott Muir

Co-founder & Chief Medical Officer

MD, DFAACAP

Dual board-certified child, adolescent and adult psychiatrist, and author of the award-winning Frontier Psychiatrists newsletter and podcast

Read more

Dr. Carlene MacMillan

Co-founder & Chief Product Officer

MD, FCTMSS, DFAACAP

Dual board-certified child, adolescent, and adult psychiatrist focused on expanding access to breakthrough treatments through better technology and insurance coverage advocacy.

Read more

John Capecelatro

CEO & Co-Founder

Elliot Cohen

Executive Chairman & Co-Founder

Stephanie Fillion

VP of Engineering

Jonathan Murray

Chief Commercial Officer

Leah Connor

VP of Operations

Take the first step and talk to a care navigator.

Your care navigator will explain the process, discuss insurance and costs, and connect you with a clinician to explore today’s most advanced mental health treatments.